XRAY
Dentsply Sirona Inc
Dentsply Sirona Inc historical holders
total: 8
Ariel Focus Fund Dentsply Sirona Inc transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Charles Bobrinskoy has been an institutional investor in Dentsply Sirona Inc (XRAY) since 2026 Q2. According to 2026 Q2 report, Charles Bobrinskoy holds 130,338 shares with a market value of roughly $1.38M representing 1.57% of their equity portfolio. The fund/company first acquired XRAY in 2026 Q2, initially purchasing 130,338 shares.
Does Charles Bobrinskoy still hold XRAY?
Yes, Charles Bobrinskoy continues to hold Dentsply Sirona Inc (XRAY). According to their 2026 Q2 report, they maintain a position of 130,338 shares valued at approximately $1.38M, representing 1.57% of their equity portfolio.
When did Charles Bobrinskoy first invest in XRAY?
Charles Bobrinskoy first invested in Dentsply Sirona Inc (XRAY) in 2026 Q2 at the reported quarter-end price of $10.61 per share, acquiring 130,338 shares in their initial purchase.
What is Charles Bobrinskoy's average cost basis for XRAY?
Based on historical transaction data, Charles Bobrinskoy's estimated cost basis for Dentsply Sirona Inc (XRAY) is approximately $10.61 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $10.61
XRAY transactions history by Ariel Focus Fund
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.57%
|
130,338
|
$10.61
|
$1,382,886
|
new
|
+1.57%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.